The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law FDA to weigh easing limits on unproven peptides As unregulated peptides grow in popularity, doctors warn of unknown risks ABC7 San Francisco The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for